Newborn Screening
Newborn screening program updates: Beginning February 17, 2026, Mucopolysaccharidosis type II (MPS II) will be included on the newborn screening panel.
What is newborn screening?
Newborn screening is a public health program that tests babies for rare genetic, metabolic, and hormonal disorders that need early diagnosis and treatment. This screening is like a safety net. It’s designed to catch rare health issues early—often before the baby shows any symptoms.

Most babies are born healthy. But for about 1 out of every 300 babies in Utah, this test helps find serious health issues that need treatments as quickly as possible for the baby to grow, develop, and live a healthy life.

What do we check for?
Utah has one of the best screening programs in the country. We check for more than 40 conditions, including:
- PKU: A condition where the body can't break down an amino acid found in food. Without treatment, it can cause irreversible brain damage.
- Cystic Fibrosis: A condition where the body produces thick mucus that affects internal organs, especially the lungs and digestive system. Treatment helps prevent infections, organ damage, and growth delays.
- Congenital hypothyroidism: A condition where the thyroid gland doesn’t produce enough hormones. Without treatment, it can cause severe developmental and growth delays.
What does newborn screening mean for you?
How it works: 2 easy steps
The First Visit
(1 to 2 days old)The Second Visit
(7 to 16 days old)What if the results are "abnormal"?
An abnormal ("screen-positive" or "out-of-range") newborn screening result indicates a higher risk for a specific medical condition, but it is not a final diagnosis. The newborn screening program will request further testing to confirm the diagnosis. If diagnosed, they will connect you with a specialty medical provider.
Common Questions:
